Rayont Inc.
$0.03+0.00%(+$0.00)
TickerSpark Score
45/100
100
Valuation
45
Profitability
20
Growth
32
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RAYT research report →
52-Week Range0% of range
Low $0.03
Current $0.03
High $0.10
Companyrayont.com
Rayont Inc. , through its subsidiary, THF Holdings Pty Ltd. , operates as a cancer treatment and medical device company.
- CEO
- Marshini Aliya Moodley
- IPO
- 2012
- Employees
- 58
- HQ
- Southport, QLD, AU
Price Chart
-70.21% · this period
Valuation
- Market Cap
- $1.46M
- P/E
- 5.69
- P/S
- 0.51
- P/B
- 0.27
- EV/EBITDA
- 6.65
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 48.69%
- Op Margin
- 31.15%
- Net Margin
- 8.62%
- ROE
- 8.14%
- ROIC
- 6.22%
Growth & Income
- Revenue
- $2.84M · 0.00%
- Net Income
- $244.86K · 0.00%
- EPS
- $0.01 · 0.00%
- Op Income
- $884.58K
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.10
- 52W Low
- $0.03
- 50D MA
- $0.03
- 200D MA
- $0.03
- Beta
- 4.85
- Avg Volume
- 6
Get TickerSpark's AI analysis on RAYT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RAYT Coverage
We haven't published any research on RAYT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RAYT Report →